Akashi, Japan

Hiroyuki Okamoto


Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 173(Granted Patents)


Location History:

  • Akashi, JA (1977)
  • Akashi, JP (1980 - 1989)
  • Kobe, JP (1992)

Company Filing History:


Years Active: 1977-1992

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Hiroyuki Okamoto: Innovator in Ophthalmic Preparations

Introduction

Hiroyuki Okamoto is a notable inventor based in Akashi, Japan. He has made significant contributions to the field of ophthalmic preparations, holding a total of 7 patents. His work focuses on innovative formulations that enhance the effectiveness of treatments for eye conditions.

Latest Patents

Among his latest patents is a flurbiprofen derivative ophthalmic preparation. This preparation comprises a fat emulsion containing flurbiprofen or its derivative, such as an ester, as an active ingredient. Another significant patent involves a fat emulsion containing a prostaglandin E.sub.1 alkyl ester, represented by a specific general formula. This fat emulsion can be administered intravenously and boasts a long half-life of its effective ingredient, prostaglandin E.sub.1 alkyl ester, in the living body, along with focus selectivity.

Career Highlights

Hiroyuki Okamoto has worked with prominent companies in the pharmaceutical industry, including The Green Cross Corporation and Taisho Pharmaceutical Co., Ltd. His career reflects a commitment to advancing medical treatments through innovative research and development.

Collaborations

Some of his notable coworkers include Kazumasa Yokoyama and Yutaka Mizushima. Their collaborative efforts have contributed to the success of various projects in the field of ophthalmology.

Conclusion

Hiroyuki Okamoto's contributions to ophthalmic preparations demonstrate his dedication to innovation in medical science. His patents reflect a deep understanding of pharmaceutical formulations that can significantly improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…